rs199947197
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001199397.3(NEK1):āc.3107C>Gā(p.Ser1036*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000208 in 1,613,606 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001199397.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEK1 | NM_001199397.3 | c.3107C>G | p.Ser1036* | stop_gained | 31/36 | ENST00000507142.6 | NP_001186326.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEK1 | ENST00000507142.6 | c.3107C>G | p.Ser1036* | stop_gained | 31/36 | 1 | NM_001199397.3 | ENSP00000424757.2 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000124 AC: 31AN: 249026Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135072
GnomAD4 exome AF: 0.000222 AC: 324AN: 1461486Hom.: 0 Cov.: 31 AF XY: 0.000226 AC XY: 164AN XY: 727006
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74292
ClinVar
Submissions by phenotype
Short-rib thoracic dysplasia 6 with or without polydactyly Pathogenic:6
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 24, 2014 | The p.Ser1036X variant in NEK1 has not been previously reported in the literature, but other variants leading to loss of function of the NEK1 protein have been reported in individuals with autosomal recessive short-rib polydactyly syndrome (Thiel 2011, Hokayem 2012). This variant has been identified in 0.04% (3/8196) of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs199947197). Other predicted loss of function variants in NEK1 gene are also rare in the general population, consistent with a pathogenic role. This nonsense variant leads to a premature termination codon at position 1036, which is predicted to lead to a truncated or absent protein. In summary, although additional studies are required to fully establish its clinical significance, the p.Ser1036X variant is likely pathogenic for short-rib polydactyly syndrome in an autosomal recessive manner based on the predicted impact on protein function. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 17, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 208600). This variant is also known as c.3107C>G (p.S1036*). This premature translational stop signal has been observed in individual(s) with clinical features of short rib-polydactyly syndrome and/or amyotrophic lateral sclerosis (PMID: 26945885, 28123176, 28935222, 29068549). This variant is present in population databases (rs199947197, gnomAD 0.03%). This sequence change creates a premature translational stop signal (p.Ser1008*) in the NEK1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEK1 are known to be pathogenic (PMID: 22499340, 29068549). - |
Pathogenic, no assertion criteria provided | research | Dan Cohn Lab, University Of California Los Angeles | Jun 01, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Dec 07, 2020 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 18, 2018 | - - |
Likely pathogenic, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | - | - - |
not provided Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 30, 2023 | Reported using alternate nomenclature p.(S1036X) as a risk allele for familial ALS but further research is needed to understand this association (Brenner et al., 2016); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 32920598, 28935222, 29068549, 34582081, 32409511, 35896380, 26945885, 28123176) - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 19, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Dec 19, 2019 | The NEK1 c.3023C>G; p.Ser1008Ter variant (rs199947197), also known as c.3107C>G; p.Ser1036Ter for NM_001199397.1, is reported in the literature in the compound heterozygous state with other pathogenic NEK1 variants in individuals affected with short rib-polydactyly syndrome II or axial spondylometaphyseal dysplasia (Wang 2017, Zhang 2018). This variant is reported in ClinVar (Variation ID: 208600), and is found in the general population with an overall allele frequency of 0.012% (33/280416 alleles) in the Genome Aggregation Database. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Wang Z et al. Axial spondylometaphyseal dysplasia is also caused by NEK1 mutations. J Hum Genet. 2017 Apr;62(4):503-506. Zhang W et al. Expanding the genetic architecture and phenotypic spectrum in the skeletal ciliopathies. Hum Mutat. 2018 Jan;39(1):152-166. - |
Short-rib thoracic dysplasia 6 with or without polydactyly;C4693523:Amyotrophic lateral sclerosis, susceptibility to, 24 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
NEK1-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 16, 2024 | The NEK1 c.3023C>G variant is predicted to result in premature protein termination (p.Ser1008*). This variant, also described as c.3107C>G (p.Ser1036*), has been reported in the compound heterozygous state in individuals with axial spondylometaphyseal dysplasia and short rib dysplasia (Wang et al. 2017. PubMed ID: 28123176; table S2, Zhang et al. 2017. PubMed ID: 29068549). This variant has also been reported in two brothers with amyotrophic lateral sclerosis (ALS) as well as in an unrelated control; however, the brothers also carried an expanded C9orf72 allele that is likely the most penetrant variant (Nguyen et al. 2017. PubMed ID: 28935222). Additionally, this variant was present in an affected brother and an unaffected brother indicating this variant exhibits incomplete penetrance, which is commonly observed in NEK1 protein-truncating variants (Brenner et al. 2016. PubMed ID: 26945885). This variant has been interpreted as pathogenic and likely pathogenic in ClinVar. Internally, we have reported this variant in multiple individuals undergoing ALS testing as well as finding this variant in the compound heterozygous state in an individual with phenotypic features consistent with short-rib polydactyly. Taken together, we classify this variant as likely pathogenic. - |
Amyotrophic lateral sclerosis, susceptibility to, 24 Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Feb 28, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at